Keith Kerr graduated BSc with first class honours in Pathology in 1978, MB ChB in 1981, followed by post-graduate training in Pathology at Edinburgh University Medical School and the Royal Infirmary of Edinburgh. He obtained MRCPath in 1988, FRCPath in 1998 and was elected Honorary FRCP(Ed) in 2006. He has been a Consultant Pathologist in Aberdeen since 1989. He was awarded an Honorary Chair in Pulmonary Pathology by the University of Aberdeen in 2006.

He has been a member of IASLC for 26 years. He is a member of the IASLC Pathology Panel, Chaired this Committee 2019-2021, and now serves as Past-Chair. He was elected to the IASLC Board of Directors for four years, 2013-2017. He is an Associate Editor for the Journal of Thoracic Oncology. He has been a member of the ESMO Thoracic Educational faculty since 2013.

He was a member of the panel for the 2004, 2015 and 2021 WHO lung cancer classifications. He is a member of the International Mesothelioma Panel, and served as Pathology chair for the EORTC lung cancer group from 2006-2014. He is Pathology Chair for the ETOP Lungscape group. He has worked on numerous clinical research lung cancer trials groups (SLCF, NCRI, UKLS), guideline development for lung cancer diagnosis and management (RCPath, SIGN, NICE, BTS, ESMO, IASLC/ETOP, IASLC/CAP/AMP), conference scientific committees (ELCC, ESMO, BTOG) and other lung cancer organization committees (UKLCC, BTOG). He serves on the international Pulmonary Pathology Society council and was a British Thoracic Society member of more than 30 years. He is a regular invited speaker and faculty member at major international conferences, both in Pathology and in Thoracic Oncology.

Keith Kerr

Aberdeen University, Aberdeen

Topic: Role of the Pathologist for the Diagnosis and the Molecular Subtyping of Lung Cancer